<DOC>
	<DOCNO>NCT02426827</DOCNO>
	<brief_summary>The study non-blinded evaluation use cervical spinal cord stimulation ( SCS ) treatment patient Hunt Hess grade 1-2 subarachnoid hemorrhage evidence cerebral vasospasm .</brief_summary>
	<brief_title>Cervical Spinal Cord Stimulation Cerebral Vasospasm</brief_title>
	<detailed_description>The study non-blinded evaluation use cervical spinal cord stimulation ( SCS ) treatment patient Hunt Hess grade 1-2 subarachnoid hemorrhage evidence cerebral vasospasm . Stimulation provide electrode place percutaneously upper cervical epidural space . The outcome 5 patient studied focus possible adverse event relate intervention . Vasospasm response treatment measure secondary outcome . Middle cerebral artery flow velocity follow transcranial Doppler clinical outcome measure NIH stroke scale . Flow velocity monitor daily transcranial Doppler NIH stroke scale perform daily 7 day , spinal cord stimulation discontinue epidural lead remove .</detailed_description>
	<mesh_term>Vasospasm , Intracranial</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<criteria>history aneurysmal subarachnoid hemorrhage aneurysm secure clip coiling . evidence vasospasm TCD MCA mean flow velocity &gt; 120 cm/s . Patients must clinically stable leave ICU study intervention . Patients Hunt Hess grade 12 nontraumatic subarachnoid hemorrhage . Patient orient patient able provide inform consent . Patients nonaneurysmal hemorrhage Patient coagulopathy ( PTT &gt; 40 , INR &gt; 1.2 ) thrombocytopenia ( platelet &lt; 100 x 103 per mm2 ) . Use anticoagulation antiplatelet medication within know clinical effective period particular medication . allergy nimodipine . History cervical thoracic spine surgery . Skin infection site catheter placement . Sepsis . Pregnancy . Age le 18 great 80 . Active diagnosis cancer history metastatic cancer . Presence cardiac defibrillator . Inability unwillingness patient give inform consent . Patients find clinically neurologically unstable , hemodynamically unstable , suffer unstable intracranial pressure time assessment lead placement intervention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>